ICAM1 and lung carcinoma: Notably, resected human samples from both breast and lung cancer brain metastasis, the two most common primary ‘brain-seeking’ cancers [24], indicated the presence of LFA-1 and ICAM-1 on tumour cells and brain parenchyma, respectively, supporting the potential translation of these findings into brain metastasis therapies.